Methodist Dallas Medical Center, Dallas, Texas, USA.
The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Am J Gastroenterol. 2019 Aug;114(8):1322-1342. doi: 10.14309/ajg.0000000000000264.
Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology.
A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets.
Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary.
Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.
目前已有详细的急性胰腺炎(AP)管理建议和指南。然而,需要质量指标(QIs)来衡量医疗保健的绩效。急性胰腺炎质量工作组的目标是使用 RAND/UCLA 适宜性方法的修改版本,正式为已知或疑似 AP 患者的管理制定 QIs。
一个由医生(胃肠病学家、医院医生和外科医生)组成的多学科专家小组,他们是各自专业的公认领导者,代表了地理和实践环境的多样性,被召集在一起。进行了文献回顾,并制定了一系列拟议的 QIs。在 3 轮中,小组成员回顾了文献,修改了 QIs,并根据科学证据、偏见、可解释性、有效性、必要性和提出的绩效目标对其进行了评分。
支持文献和一份横跨 10 个 AP 领域(诊断、病因、初步评估和风险分层等)的 71 个拟议 QIs 的清单被发送给专家小组进行审查,并在第 1 轮(95%的小组成员参与)中独立评分。根据第 2 轮 QIs 的面对面讨论(75%的参与),41 个 QIs 被归类为有效。在第 3 轮(90%的参与)中,小组成员对 41 个有效 QIs 的必要性和提出的绩效阈值进行了评分。最终的分类确定 40 个 QIs 既有效又必要。
管理已知或疑似 AP 患者的医院和提供者应确保患者根据当前循证最佳实践接受高质量的护理和期望的结果。这项由医生领导的倡议正式制定了 40 个 AP 管理的 QIs 和绩效阈值目标。有效的 QIs 为卫生系统提供了一个可靠的定量框架,以监测向已知或疑似 AP 患者提供的护理质量。